TE AIM+CD8+ was the only subset that increased significantly after 9 months post-infection (average 29% vs. 17%, p < 0.05), indicating the importance of CD8+ T-cell effector mechanisms for protection in case of subsequent challenges by SARS-CoV-2 antigens (Figure 3C). Here, CD8A is linked to infection.